Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic targetMarianne Hütt-Cabezas, Fausto J. Rodríguez, Iren Horkayne‐Szakaly et al.|Neuro-Oncology|2013Cited by 80
Abstract 2888: Targeting the fatal pediatric brain tumors AT/RT and DIPG with the DNA binding agent quinacrineHarpreet Kaur, Eric H. Raabe, Charles G. Eberhart et al.|Tumor Biology|2019Cited by 1
ATRT-38. TAK228 COMBINES WITH NAVITOCLAX TO ENHANCE PLATINUM-INDUCED CYTOTOXICITY IN AT/RTJeffrey Rubens, Eric H. Raabe, Sabrina Wang et al.|Neuro-Oncology|2018Cited by 0
Abstract 3449: A novel rapid zebrafish model for validation of potential therapies for fatal pediatric brain tumorsHarpreet Kaur, Eric H. Raabe, Kevin Emmerich et al.|Cancer Research|2020Cited by 0
Abstract 2888: Targeting the fatal pediatric brain tumors AT/RT and DIPG with the DNA binding agent quinacrineHarpreet Kaur, Eric H. Raabe, Charles G. Eberhart et al.|Cancer Research|2019Cited by 0